PhaseBio Pharmaceuticals Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending March 31, 2022 was 40.52% (a 14.5% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth increased by 556.73%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 27.87% (a 95.72% increase from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 14.24% (a -89.19% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 131.73% (a 16.68% increase from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending March 31, 2022 was 25.61% (a 85.04% increase compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth increased by 2777.53% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
25.61% 13.84% 3.66% 0.89%
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of PhaseBio Pharmaceuticals

Most recent Selling, General and Administrative (SG&A) Expenses Growthof PHAS including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 40.52%
2021 35.39% 20.77% 6.17% -9.69% 27.87%
2020 -1.42% 9.74% 34.86% 36.4% 14.24%
2019 63.45% 165.44% 162.16% 260.19% 131.73%
2018 296.64% -62.33% -61.86% -72.24% 112.9%
2017 -74.79% 9.79%
2016 -8.92%

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology